Kolon TissueGene, Inc. (KOSDAQ:950160)

Kolon TissueGene Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	53,218	802.87	27,433	41,563	38,813	18,522
Short-Term Investments	-	-	-	16,700	200.03	37,808
Cash & Short-Term Investments	53,218	802.87	27,433	58,263	39,013	56,330
Cash Growth	341.87%	-97.07%	-52.92%	49.34%	-30.74%	-46.38%
Accounts Receivable	253.42	237.73	183.58	33.64	334.24	583.7
Other Receivables	48.35	25.84	1,195	700.99	8.56	154.6
Receivables	301.76	263.58	1,378	734.62	342.8	738.3
Inventory	60.1	93.46	64.28	16.56	170.58	341.6
Prepaid Expenses	1,617	1,435	1,283	1,252	1,536	1,557
Other Current Assets	6,285	4,821	1,872	2,804	2,386	4,047
Total Current Assets	61,482	7,415	32,031	63,070	43,449	63,014
Property, Plant & Equipment	6,767	6,971	7,061	8,157	8,945	9,132
Other Intangible Assets	168.68	182.12	126.01	234.49	202.97	277.6
Long-Term Deferred Charges	233,130	200,081	87,539	30,990	5,790	-
Other Long-Term Assets	7,534	7,639	8,154	7,439	3,013	348.45
Total Assets	309,082	222,288	134,910	109,890	61,399	72,839
Accounts Payable	315.99	325.38	253.51	102.69	90.35	259.6
Accrued Expenses	2,566	3,200	1,709	2,529	9,901	4,082
Short-Term Debt	29,475	10,894	-	-	-	5,440
Current Portion of Leases	1,146	1,072	907.64	800.14	654.92	686.98
Current Unearned Revenue	1.95	8.95	9	-	-	-
Other Current Liabilities	86,739	55,610	11,424	8,172	5,496	4,729
Total Current Liabilities	120,244	71,111	14,303	11,604	16,143	15,197
Long-Term Debt	-	-	-	-	-	2,720
Long-Term Leases	5,126	5,274	5,568	6,273	6,578	6,647
Other Long-Term Liabilities	-	0	75.75	524.12	31	166
Total Liabilities	125,388	76,384	19,947	18,401	22,752	24,730
Common Stock	2.39	2.34	1.88	1.75	1.54	1.33
Additional Paid-In Capital	630,065	587,429	470,458	424,164	339,585	279,117
Retained Earnings	-446,372	-441,532	-355,250	-332,401	-300,732	-230,843
Comprehensive Income & Other	-3.11	2.73	-248.43	-277.49	-208.79	-168.65
Total Common Equity	183,693	145,902	114,962	91,487	38,646	48,107
Shareholders' Equity	183,694	145,904	114,963	91,489	38,648	48,108
Total Liabilities & Equity	309,082	222,288	134,910	109,890	61,399	72,839
Total Debt	35,746	17,240	6,476	7,074	7,233	15,494
Net Cash (Debt)	17,472	-16,437	20,957	51,189	31,781	40,836
Net Cash Growth	217.10%	-	-59.06%	61.07%	-22.18%	-50.35%
Net Cash Per Share	220.45	-213.60	292.25	772.24	519.01	668.80
Filing Date Shares Outstanding	80.31	80.04	73.21	69.97	61.91	60.89
Total Common Shares Outstanding	80.31	80.04	73.21	69.97	61.91	60.89
Working Capital	-58,761	-63,695	17,727	51,466	27,306	47,817
Book Value Per Share	2287.16	1822.92	1570.27	1307.54	624.28	790.08
Tangible Book Value	183,524	145,720	114,836	91,253	38,443	47,829
Tangible Book Value Per Share	2285.05	1820.65	1568.55	1304.18	621.00	785.52
Machinery	979.13	1,035	910.56	965.54	276.33	857.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.